Nancy M P King

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi The ethics of genetic testing: is more always better?
    Nancy M P King
    Department of Social Sciences and Health Policy, Program in Bioethics, Health, and Society, Wake Forest University School of Medicine, USA
    N C Med J 68:112-4. 2007
  2. ncbi Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium
    Mark A Hall
    Division of Public Health Sciences, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA
    Clin Trials 7:S33-45. 2010
  3. ncbi Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting
    Mark A Hall
    Center for Bioethics, Health and Society, Public Health Sciences, Wake Forest University, Winston Salem, North Carolina 27157 1063, USA
    Acad Med 85:1554-6. 2010
  4. ncbi The line between clinical innovation and human experimentation
    Nancy M P King
    UNC-Chapel Hill, USA
    Seton Hall Law Rev 32:571-80. 2003
  5. ncbi Genes and Tourette syndrome: scientific, ethical, and social implications
    Nancy M P King
    School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
    Adv Neurol 99:144-7. 2006
  6. ncbi Clinical trials and medical care: defining the therapeutic misconception
    Gail E Henderson
    University of North Carolina at ChapelHill, Chapel Hill, North Carolina, United Statesof America
    PLoS Med 4:e324. 2007

Collaborators

Detail Information

Publications6

  1. ncbi The ethics of genetic testing: is more always better?
    Nancy M P King
    Department of Social Sciences and Health Policy, Program in Bioethics, Health, and Society, Wake Forest University School of Medicine, USA
    N C Med J 68:112-4. 2007
  2. ncbi Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium
    Mark A Hall
    Division of Public Health Sciences, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA
    Clin Trials 7:S33-45. 2010
    ..and..
  3. ncbi Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting
    Mark A Hall
    Center for Bioethics, Health and Society, Public Health Sciences, Wake Forest University, Winston Salem, North Carolina 27157 1063, USA
    Acad Med 85:1554-6. 2010
    ..In addition, the surplus from research budgets is not shared directly with individual investigators. However, further investigation is needed to determine whether practices outside AMCs pose greater concerns...
  4. ncbi The line between clinical innovation and human experimentation
    Nancy M P King
    UNC-Chapel Hill, USA
    Seton Hall Law Rev 32:571-80. 2003
  5. ncbi Genes and Tourette syndrome: scientific, ethical, and social implications
    Nancy M P King
    School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA
    Adv Neurol 99:144-7. 2006
  6. ncbi Clinical trials and medical care: defining the therapeutic misconception
    Gail E Henderson
    University of North Carolina at ChapelHill, Chapel Hill, North Carolina, United Statesof America
    PLoS Med 4:e324. 2007